3-Deazaadenosine and L-homocysteine inhibit human platelet activation induced by arachidonic acid, U46619 and phospholipase C.
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D000242:Cyclic AMP / Q000096:biosynthesis; D006710:Homocysteine / Q000494:pharmacology*; D006801:Humans; D007536:Isomerism; D008745:Methylation; D010974:Platelet Aggregation / Q000187:drug effects*; D011450:Prostaglandin Endoperoxides, Synthetic / Q000037:antagonists & inhibitors; D011453:Prostaglandins / Q000096:biosynthesis; D012263:Ribonucleosides / Q000494:pharmacology*; D013917:Thrombin / Q000037:antagonists & inhibitors; D014372:Tubercidin / Q000494:pharmacology*; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors
D001095:Arachidonic Acids; D011450:Prostaglandin Endoperoxides, Synthetic; D011453:Prostaglandins; D012263:Ribonucleosides; C018258:3-deazaadenosine; D006710:Homocysteine; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000242:Cyclic AMP; D010738:Type C Phospholipases; D013917:Thrombin; D014372:Tubercidin